Medinoah is a technologically drug R&D service company that provides global biomedical companies with R&D services based on synthetic chemistry/analytical chemistry core competitiveness from drug synthesis, screening and structure optimization, production process development, total quality research to cGMP production. The company was founded in 2008 and is based in Suzhou, China.
Medinoah Frequently Asked Questions (FAQ)
When was Medinoah founded?
Medinoah was founded in 2008.
Where is Medinoah's headquarters?
Medinoah's headquarters is located at Room 501, Building C9, Bio-Nano Park, No.218 Xinghu Street, Suzhou Industrial Park, Suzhou.
What is Medinoah's latest funding round?
Medinoah's latest funding round is Series B.
How much did Medinoah raise?
Medinoah raised a total of $15.46M.
Who are the investors of Medinoah?
Investors of Medinoah include Oriza Holdings, Addor Capital, Hankang Equity Investment Management, Zhongxin Innovation Capital, Jiadinghui Equity Investment and 5 more.